In vitro activity of sparfloxacin compared with those of five other quinolones
about
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophiliaActivity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitroEfficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitisEfficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapyStudy of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologySusceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenemPharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro.High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rodsActive efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.Trovafloxacin: a new fluoroquinolone.Levofloxacin and sparfloxacin: new quinolone antibiotics.Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.Intracellular accumulation of norfloxacin in Mycobacterium smegmatisBactericidal effect of sparfloxacin alone and in combination with amoxicillin against Streptococcus pneumoniae as determined by kill-kinetic studies.Intercalation of a Zn(II) complex containing ciprofloxacin drug between DNA base pairs.
P2860
Q24533461-F1BB8D72-3CE1-496A-AB10-7AC263890DB2Q24673222-A79C3AE5-D658-42D1-8F60-2FD38303884AQ28263381-54DD1707-1E2E-41B1-B336-145B45D6C1ACQ33692694-4FEFE992-F63C-4682-880B-9ADFB6F73951Q33693467-789658C2-0A23-438A-8DAC-1982C40F0950Q33751682-5B4653C5-3F9E-4AB7-92F6-2F3A6E5A2E30Q33751794-324AC969-A0DE-40D6-8E17-E97488B79169Q33758620-88B6582F-A6C0-4FC0-9B91-AD16999BC808Q35123308-D44EA758-F9CF-4DFF-B047-71F60ABB42B9Q35123325-65937CB7-1F9A-4BD6-B3AC-7E986DF6843DQ35128876-336FEC32-DBA1-40FB-8B76-803A2FC3D6E0Q35129977-9C712F36-E371-412E-8B4D-E94561FE909DQ35136059-2509D333-A9FC-4E7D-AD82-9A52FC60D6D3Q35137076-BE7DFBC8-DFF4-4B1E-A853-9281205938B9Q35138154-1AC33517-7AA9-4472-B8D7-BCC165D4A58BQ35822840-8A7B9384-231A-45B3-BB2C-E795E91D5E70Q37879173-D55479BE-E58F-45FD-A87F-18E5D9A1089EQ37881273-A3698F21-EA3B-4FEF-A610-71480DD4494EQ39557385-17AB0CB3-E1C7-4929-9A37-A164C342AAAEQ39780762-04FA2255-0604-4142-B3A8-1A61406EDF56Q43580576-C78F4BA0-D8E3-4CD0-88B2-CBA8DEB7EAD3Q49553791-4D518969-D1A0-461C-AFD2-8A903465B273
P2860
In vitro activity of sparfloxacin compared with those of five other quinolones
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
In vitro activity of sparfloxacin compared with those of five other quinolones
@ast
In vitro activity of sparfloxacin compared with those of five other quinolones
@en
type
label
In vitro activity of sparfloxacin compared with those of five other quinolones
@ast
In vitro activity of sparfloxacin compared with those of five other quinolones
@en
prefLabel
In vitro activity of sparfloxacin compared with those of five other quinolones
@ast
In vitro activity of sparfloxacin compared with those of five other quinolones
@en
P2093
P2860
P356
P1476
In vitro activity of sparfloxacin compared with those of five other quinolones
@en
P2093
P2860
P304
P356
10.1128/AAC.36.3.558
P407
P577
1992-03-01T00:00:00Z